BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+3.95%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$9.45B
AUM Growth
+$9.45B
(+8.2%)
Cap. Flow
+$607M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
29.09%
Holding
237
New
15
Increased
96
Reduced
78
Closed
21
Top Buys
| 1 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$53.3M |
| 2 |
ESSA Pharma
EPIX
|
$53M |
| 3 |
Revolution Medicines
RVMD
|
$47.1M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$39.8M |
| 5 |
Becton Dickinson
BDX
|
$32.4M |
Top Sells
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$100M |
| 2 |
Halozyme
HALO
|
$43.1M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$38.1M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$33.3M |
| 5 |
Esperion Therapeutics
ESPR
|
$32.2M |
Sector Composition
| 1 | Healthcare | 95.93% |
| 2 | Industrials | 0.88% |
| 3 | Technology | 0.47% |
| 4 | Consumer Discretionary | 0.04% |
| 5 | Financials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Pfizer
PFE
$141B
| – | – |
-73,900
| Closed | -$2.72M |
|
227
Interactive Brokers
IBKR
$28.5B
| – | – |
-9,400
| Closed | -$573K |
|
228
GoHealth
GOCO
$77.4M
| – | – |
-337,423
| Closed | -$4.61M |
|
229
Galapagos
GLPG
$2.06B
| – | – |
-9,500
| Closed | -$940K |
|
230
Quest Diagnostics
DGX
$20.1B
| – | – |
-6,749
| Closed | -$804K |
|
231
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| – | – |
-149,000
| Closed | -$2.59M |
|
232
Cidara Therapeutics
CDTX
$1.61B
| – | – |
-2,822,495
| Closed | -$5.65M |
|
233
Broadridge
BR
$29.3B
| – | – |
-3,400
| Closed | -$521K |
|
234
Blackbaud
BLKB
$3.23B
| – | – |
-4,107
| Closed | -$236K |
|
235
Avient
AVNT
$3.35B
| – | – |
-13,600
| Closed | -$548K |
|
236
Autoliv
ALV
$9.56B
| – | – |
-6,800
| Closed | -$626K |
|
237
Analog Devices
ADI
$120B
| – | – |
-4,100
| Closed | -$606K |
|